{"pmid":32500431,"title":"Continuing our work: transplant surgery and surgical oncology in a tertiary referral COVID-19 center.","text":["Continuing our work: transplant surgery and surgical oncology in a tertiary referral COVID-19 center.","COVID-19 is rapidly spreading worldwide. Healthcare systems are struggling to properly allocate resources while ensuring cure for diseases outside of the infection. The aim of this study was to demonstrate how surgical activity was affected by the virus outbreak and show the changes in practice in a tertiary referral COVID-19 center. The official bulletins of the Italian National Institute for the Infectious Diseases \"L. Spallanzani\" were reviewed to retrieve the number of daily COVID-19 patients. Records of consecutive oncological and transplant procedures performed during the outbreak were reviewed. Patients with a high probability of postoperative intensive care unit (ICU) admission were considered as high risk and defined by an ASA score >/= III and/or a Charlson Comorbidity Index (CCI) >/= 6 and/or a Revised Cardiac Risk Index for Preoperative Risk (RCRI) >/= 3. 72 patients were operated, including 12 (16.6%) liver and kidney transplantations. Patients had few comorbidities (26.3%), low ASA score (1.9 +/- 0.5), CCI (3.7 +/- 1.3), and RCRI (1.2 +/- 0.6) and had overall a low risk of postoperative ICU admission. Few patients had liver cirrhosis (12.5%) or received preoperative systemic therapy (16.6%). 36 (50%) high-risk surgical procedures were performed, including major hepatectomies, pancreaticoduodenectomies, total gastrectomies, multivisceral resections, and transplantations. Despite this, only 15 patients (20.8%) were admitted to the ICU. Only oncologic cases and transplantations were performed during the COVID-19 outbreak. Careful selection of patients allowed to perform major cancer surgeries and transplantations without further stressing hospital resources, meanwhile minimizing collateral damage to patients.","Updates Surg","Berardi, Giammauro","Colasanti, Marco","Levi Sandri, Giovanni Battista","Del Basso, Celeste","Ferretti, Stefano","Laurenzi, Andrea","Guglielmo, Nicola","Meniconi, Roberto Luca","Antonini, Mario","D'Offizi, Gianpiero","Ettorre, Giuseppe Maria","32500431"],"abstract":["COVID-19 is rapidly spreading worldwide. Healthcare systems are struggling to properly allocate resources while ensuring cure for diseases outside of the infection. The aim of this study was to demonstrate how surgical activity was affected by the virus outbreak and show the changes in practice in a tertiary referral COVID-19 center. The official bulletins of the Italian National Institute for the Infectious Diseases \"L. Spallanzani\" were reviewed to retrieve the number of daily COVID-19 patients. Records of consecutive oncological and transplant procedures performed during the outbreak were reviewed. Patients with a high probability of postoperative intensive care unit (ICU) admission were considered as high risk and defined by an ASA score >/= III and/or a Charlson Comorbidity Index (CCI) >/= 6 and/or a Revised Cardiac Risk Index for Preoperative Risk (RCRI) >/= 3. 72 patients were operated, including 12 (16.6%) liver and kidney transplantations. Patients had few comorbidities (26.3%), low ASA score (1.9 +/- 0.5), CCI (3.7 +/- 1.3), and RCRI (1.2 +/- 0.6) and had overall a low risk of postoperative ICU admission. Few patients had liver cirrhosis (12.5%) or received preoperative systemic therapy (16.6%). 36 (50%) high-risk surgical procedures were performed, including major hepatectomies, pancreaticoduodenectomies, total gastrectomies, multivisceral resections, and transplantations. Despite this, only 15 patients (20.8%) were admitted to the ICU. Only oncologic cases and transplantations were performed during the COVID-19 outbreak. Careful selection of patients allowed to perform major cancer surgeries and transplantations without further stressing hospital resources, meanwhile minimizing collateral damage to patients."],"journal":"Updates Surg","authors":["Berardi, Giammauro","Colasanti, Marco","Levi Sandri, Giovanni Battista","Del Basso, Celeste","Ferretti, Stefano","Laurenzi, Andrea","Guglielmo, Nicola","Meniconi, Roberto Luca","Antonini, Mario","D'Offizi, Gianpiero","Ettorre, Giuseppe Maria"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32500431","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s13304-020-00825-3","keywords":["covid-19","general surgery","surgical oncology"],"topics":["Prevention"],"weight":1,"_version_":1668804508795273217,"score":9.490897,"similar":[{"pmid":32354990,"title":"Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study.","text":["Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study.","OBJECTIVES: COVID-19 has rapidly become a major health emergency worldwide. Patients with IBD are at increased risk of infection, especially when they have active disease and are taking immunosuppressive therapy. The characteristics and outcomes of COVID-19 in patients with IBD remain unclear. DESIGN: This Italian prospective observational cohort study enrolled consecutive patients with an established IBD diagnosis and confirmed COVID-19. Data regarding age, sex, IBD (type, treatments and clinical activity), other comorbidities (Charlson Comorbidity Index (CCI)), signs and symptoms of COVID-19 and therapies were compared with COVID-19 outcomes (pneumonia, hospitalisation, respiratory therapy and death). RESULTS: Between 11 and 29 March 2020, 79 patients with IBD with COVID-19 were enrolled at 24 IBD referral units. Thirty-six patients had COVID-19-related pneumonia (46%), 22 (28%) were hospitalised, 7 (9%) required non-mechanical ventilation, 9 (11%) required continuous positive airway pressure therapy, 2 (3%) had endotracheal intubation and 6 (8%) died. Four patients (6%) were diagnosed with COVID-19 while they were being hospitalised for a severe flare of IBD. Age over 65 years (p=0.03), UC diagnosis (p=0.03), IBD activity (p=0.003) and a CCI score >1 (p=0.04) were significantly associated with COVID-19 pneumonia, whereas concomitant IBD treatments were not. Age over 65 years (p=0.002), active IBD (p=0.02) and higher CCI score were significantly associated with COVID-19-related death. CONCLUSIONS: Active IBD, old age and comorbidities were associated with a negative COVID-19 outcome, whereas IBD treatments were not. Preventing acute IBD flares may avoid fatal COVID-19 in patients with IBD. Further research is needed.","Gut","Bezzio, Cristina","Saibeni, Simone","Variola, Angela","Allocca, Mariangela","Massari, Alessandro","Gerardi, Viviana","Casini, Valentina","Ricci, Chiara","Zingone, Fabiana","Amato, Arnaldo","Caprioli, Flavio","Lenti, Marco Vincenzo","Vigano, Chiara","Ascolani, Marta","Bossa, Fabrizio","Castiglione, Fabiana","Cortelezzi, Claudio","Grossi, Laurino","Milla, Monica","Morganti, Daniela","Pastorelli, Luca","Ribaldone, Davide Giuseppe","Sartini, Alessandro","Soriano, Alessandra","Manes, Gianpiero","Danese, Silvio","Fantini, Massimo","Armuzzi, Alessandro","Daperno, Marco","Fiorino, Gionata","32354990"],"abstract":["OBJECTIVES: COVID-19 has rapidly become a major health emergency worldwide. Patients with IBD are at increased risk of infection, especially when they have active disease and are taking immunosuppressive therapy. The characteristics and outcomes of COVID-19 in patients with IBD remain unclear. DESIGN: This Italian prospective observational cohort study enrolled consecutive patients with an established IBD diagnosis and confirmed COVID-19. Data regarding age, sex, IBD (type, treatments and clinical activity), other comorbidities (Charlson Comorbidity Index (CCI)), signs and symptoms of COVID-19 and therapies were compared with COVID-19 outcomes (pneumonia, hospitalisation, respiratory therapy and death). RESULTS: Between 11 and 29 March 2020, 79 patients with IBD with COVID-19 were enrolled at 24 IBD referral units. Thirty-six patients had COVID-19-related pneumonia (46%), 22 (28%) were hospitalised, 7 (9%) required non-mechanical ventilation, 9 (11%) required continuous positive airway pressure therapy, 2 (3%) had endotracheal intubation and 6 (8%) died. Four patients (6%) were diagnosed with COVID-19 while they were being hospitalised for a severe flare of IBD. Age over 65 years (p=0.03), UC diagnosis (p=0.03), IBD activity (p=0.003) and a CCI score >1 (p=0.04) were significantly associated with COVID-19 pneumonia, whereas concomitant IBD treatments were not. Age over 65 years (p=0.002), active IBD (p=0.02) and higher CCI score were significantly associated with COVID-19-related death. CONCLUSIONS: Active IBD, old age and comorbidities were associated with a negative COVID-19 outcome, whereas IBD treatments were not. Preventing acute IBD flares may avoid fatal COVID-19 in patients with IBD. Further research is needed."],"journal":"Gut","authors":["Bezzio, Cristina","Saibeni, Simone","Variola, Angela","Allocca, Mariangela","Massari, Alessandro","Gerardi, Viviana","Casini, Valentina","Ricci, Chiara","Zingone, Fabiana","Amato, Arnaldo","Caprioli, Flavio","Lenti, Marco Vincenzo","Vigano, Chiara","Ascolani, Marta","Bossa, Fabrizio","Castiglione, Fabiana","Cortelezzi, Claudio","Grossi, Laurino","Milla, Monica","Morganti, Daniela","Pastorelli, Luca","Ribaldone, Davide Giuseppe","Sartini, Alessandro","Soriano, Alessandra","Manes, Gianpiero","Danese, Silvio","Fantini, Massimo","Armuzzi, Alessandro","Daperno, Marco","Fiorino, Gionata"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32354990","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1136/gutjnl-2020-321411","keywords":["ibd","epidemiology"],"locations":["Italian","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666138495224119296,"score":280.8189},{"pmid":32482977,"title":"Hip Fracture Outcomes During the COVID-19 Pandemic: Early Results from New York.","text":["Hip Fracture Outcomes During the COVID-19 Pandemic: Early Results from New York.","OBJECTIVE: To evaluate inpatient outcomes among hip fracture patients treated during the COVID-19 pandemic in New York City. DESIGN: Multicenter retrospective cohort study SETTING:: One Level 1 Trauma Center and one orthopaedic specialty hospital in New York CityPatients/Participants: Fifty-nine consecutive patients (average age 85, range: 65 - 100 years) treated for a hip fracture (OTA/AO 31, 32.1) over a 5-week period, March 20, 2020 to April 24, 2020, during the height of the COVID-19 crisis. MAIN OUTCOME MEASUREMENTS: COVID-19 infection status was used to stratify patients. The primary outcome was inpatient mortality. Secondary outcomes were admission to the intensive care unit, unexpected intubation, pneumonia, deep venous thrombosis, pulmonary embolus, myocardial infarction, cerebrovascular accident, urinary tract infection, and transfusion. Baseline demographics, comorbidities, treatment characteristics, and COVID-related symptomatology were also evaluated. RESULTS: Ten patients (15%) tested positive for COVID-19 (COVID+) (n=9; 7 preoperatively, 2 postoperatively) or were presumed positive (n=1), 40 (68%) patients tested negative, and 9 (15%) patients were not tested in the primary hospitalization. American Society of Anesthesiologists (ASA) scores were higher in the COVID+ group (d=-0.83; p=0.04); however, the Charlson Comorbidity Index was similar between the study groups (d=-0.17; p=0.63). Inpatient mortality was significantly increased in the COVID+ cohort (56% vs. 4%; OR 30.0, 95% CI 4.3-207; p=0.001). Including the one presumed positive case in the COVID+ cohort increased this difference (60% vs. 2%; OR 72.0, 95% CI 7.9-754; p<0.001). CONCLUSIONS: Hip fracture patients with concomitant COVID-19 infection had worse ASA scores but similar baseline comorbidities with significantly higher rates of inpatient mortality compared to those without concomitant COVID-19 infection. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.","J Orthop Trauma","LeBrun, Drake G","Konnaris, Maxwell A","Ghahramani, Gregory C","Premkumar, Ajay","DeFrancesco, Chris J","Gruskay, Jordan A","Dvorzhinskiy, Aleksey","Sandhu, Milan S","Goldwyn, Elan M","Mendias, Christopher L","Ricci, William M","32482977"],"abstract":["OBJECTIVE: To evaluate inpatient outcomes among hip fracture patients treated during the COVID-19 pandemic in New York City. DESIGN: Multicenter retrospective cohort study SETTING:: One Level 1 Trauma Center and one orthopaedic specialty hospital in New York CityPatients/Participants: Fifty-nine consecutive patients (average age 85, range: 65 - 100 years) treated for a hip fracture (OTA/AO 31, 32.1) over a 5-week period, March 20, 2020 to April 24, 2020, during the height of the COVID-19 crisis. MAIN OUTCOME MEASUREMENTS: COVID-19 infection status was used to stratify patients. The primary outcome was inpatient mortality. Secondary outcomes were admission to the intensive care unit, unexpected intubation, pneumonia, deep venous thrombosis, pulmonary embolus, myocardial infarction, cerebrovascular accident, urinary tract infection, and transfusion. Baseline demographics, comorbidities, treatment characteristics, and COVID-related symptomatology were also evaluated. RESULTS: Ten patients (15%) tested positive for COVID-19 (COVID+) (n=9; 7 preoperatively, 2 postoperatively) or were presumed positive (n=1), 40 (68%) patients tested negative, and 9 (15%) patients were not tested in the primary hospitalization. American Society of Anesthesiologists (ASA) scores were higher in the COVID+ group (d=-0.83; p=0.04); however, the Charlson Comorbidity Index was similar between the study groups (d=-0.17; p=0.63). Inpatient mortality was significantly increased in the COVID+ cohort (56% vs. 4%; OR 30.0, 95% CI 4.3-207; p=0.001). Including the one presumed positive case in the COVID+ cohort increased this difference (60% vs. 2%; OR 72.0, 95% CI 7.9-754; p<0.001). CONCLUSIONS: Hip fracture patients with concomitant COVID-19 infection had worse ASA scores but similar baseline comorbidities with significantly higher rates of inpatient mortality compared to those without concomitant COVID-19 infection. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence."],"journal":"J Orthop Trauma","authors":["LeBrun, Drake G","Konnaris, Maxwell A","Ghahramani, Gregory C","Premkumar, Ajay","DeFrancesco, Chris J","Gruskay, Jordan A","Dvorzhinskiy, Aleksey","Sandhu, Milan S","Goldwyn, Elan M","Mendias, Christopher L","Ricci, William M"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32482977","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1097/BOT.0000000000001849","locations":["New York","New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1668532114884132865,"score":226.19566},{"pmid":32298036,"title":"Framework for prioritizing head and neck surgery during the COVID-19 pandemic.","text":["Framework for prioritizing head and neck surgery during the COVID-19 pandemic.","The COVID-19 pandemic has placed an extraordinary demand on the United States health care system. Many institutions have canceled elective and non-urgent procedures to conserve resources and limit exposure. While operational definitions of elective and urgent categories exist, there is a degree of surgeon judgment in designation. In the present commentary, we provide a framework for prioritizing head and neck surgery during the pandemic. Unique considerations for the head and neck patient are examined including risk to the oncology patient, outcomes following delay in head and neck cancer therapy, and risk of transmission during otolaryngologic surgery. Our case prioritization criteria consist of four categories: urgent-proceed with surgery, less urgent-consider postpone > 30 days, less urgent-consider postpone 30 to 90 days, and case-by-case basis. Finally, we discuss our preoperative clinical pathway for transmission mitigation including defining low-risk and high-risk surgery for transmission and role of preoperative COVID-19 testing.","Head Neck","Topf, Michael C","Shenson, Jared A","Holsinger, F Christopher","Wald, Samuel H","Cianfichi, Lisa J","Rosenthal, Eben L","Sunwoo, John B","32298036"],"abstract":["The COVID-19 pandemic has placed an extraordinary demand on the United States health care system. Many institutions have canceled elective and non-urgent procedures to conserve resources and limit exposure. While operational definitions of elective and urgent categories exist, there is a degree of surgeon judgment in designation. In the present commentary, we provide a framework for prioritizing head and neck surgery during the pandemic. Unique considerations for the head and neck patient are examined including risk to the oncology patient, outcomes following delay in head and neck cancer therapy, and risk of transmission during otolaryngologic surgery. Our case prioritization criteria consist of four categories: urgent-proceed with surgery, less urgent-consider postpone > 30 days, less urgent-consider postpone 30 to 90 days, and case-by-case basis. Finally, we discuss our preoperative clinical pathway for transmission mitigation including defining low-risk and high-risk surgery for transmission and role of preoperative COVID-19 testing."],"journal":"Head Neck","authors":["Topf, Michael C","Shenson, Jared A","Holsinger, F Christopher","Wald, Samuel H","Cianfichi, Lisa J","Rosenthal, Eben L","Sunwoo, John B"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298036","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1002/hed.26184","keywords":["covid-19","sars-cov-2","clinical practice guidelines","head and neck cancer","surgical oncology"],"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138493331439616,"score":184.0402},{"pmid":32454041,"title":"An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise.","text":["An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise.","BACKGROUND: The outbreak of Covid-19 has vastly increased the operational burden on healthcare systems worldwide. For patients with end-stage liver failure, liver transplantation is the only option. However, the strain on intensive care facilities caused by the pandemic is a major concern. There is an urgent need for ethical frameworks to balance the need for liver transplantation against the availability of national resources. METHODS: We performed an international multi-center study of transplant centers to understand the evolution of policies for transplant prioritization in response to the pandemic in March 2020. To describe the ethical tension arising in this setting, we propose a novel ethical framework, the Quadripartite Equipoise (QE) score, that is applicable to liver transplantation in the context of limited national resources. RESULTS: Seventeen large- and medium- sized liver transplant centers from twelve countries across four continents participated. Ten centers opted to limit transplant activity in response to the pandemic, favoring a \"sickest-first\" approach. Conversely, some larger centers opted to continue routine transplant activity in order to balance waiting list mortality. To model these and other ethical tensions, we computed a QE score using 4 factors - Recipient Outcome, Donor/Graft Safety, Waiting List Mortality and Healthcare Resources for seven countries. The fluctuation of the QE score over time accurately reflects the dynamic changes in the ethical tensions surrounding transplant activity in a pandemic. CONCLUSIONS: This four-dimensional model of Quadripartite Equipoise addresses the ethical tensions in the current pandemic. It serves as a universally applicable framework to guide regulation of transplant activity in response to the increasing burden on healthcare systems to allow greater global solidarity and transparency in these austere times.","J Hepatol","Chew, Claire Alexandra","Iyer, Shridhar Ganpathi","Chieh Kow, Alfred Wei","Madhavan, Krishnakumar","Teng Wong, Andrea Sze","Halazun, Karim J","Battula, Narendra","Scalera, Irene","Angelico, Roberta","Farid, Sharid","Buchholz, Bettina M","Rotellar, Fernando","Chi-Yan Chan, Albert","Kim, Jong Man","Wang, Chih-Chi","Pitchaimuthu, Maheswaran","Reddy, Mettu Srinivas","Soin, Arvinder Singh","Derosas, Carlos","Imventarza, Oscar","Isaac, John","Muiesan, Paolo","Mirza, Darius F","Bonney, Glenn Kunnath","32454041"],"abstract":["BACKGROUND: The outbreak of Covid-19 has vastly increased the operational burden on healthcare systems worldwide. For patients with end-stage liver failure, liver transplantation is the only option. However, the strain on intensive care facilities caused by the pandemic is a major concern. There is an urgent need for ethical frameworks to balance the need for liver transplantation against the availability of national resources. METHODS: We performed an international multi-center study of transplant centers to understand the evolution of policies for transplant prioritization in response to the pandemic in March 2020. To describe the ethical tension arising in this setting, we propose a novel ethical framework, the Quadripartite Equipoise (QE) score, that is applicable to liver transplantation in the context of limited national resources. RESULTS: Seventeen large- and medium- sized liver transplant centers from twelve countries across four continents participated. Ten centers opted to limit transplant activity in response to the pandemic, favoring a \"sickest-first\" approach. Conversely, some larger centers opted to continue routine transplant activity in order to balance waiting list mortality. To model these and other ethical tensions, we computed a QE score using 4 factors - Recipient Outcome, Donor/Graft Safety, Waiting List Mortality and Healthcare Resources for seven countries. The fluctuation of the QE score over time accurately reflects the dynamic changes in the ethical tensions surrounding transplant activity in a pandemic. CONCLUSIONS: This four-dimensional model of Quadripartite Equipoise addresses the ethical tensions in the current pandemic. It serves as a universally applicable framework to guide regulation of transplant activity in response to the increasing burden on healthcare systems to allow greater global solidarity and transparency in these austere times."],"journal":"J Hepatol","authors":["Chew, Claire Alexandra","Iyer, Shridhar Ganpathi","Chieh Kow, Alfred Wei","Madhavan, Krishnakumar","Teng Wong, Andrea Sze","Halazun, Karim J","Battula, Narendra","Scalera, Irene","Angelico, Roberta","Farid, Sharid","Buchholz, Bettina M","Rotellar, Fernando","Chi-Yan Chan, Albert","Kim, Jong Man","Wang, Chih-Chi","Pitchaimuthu, Maheswaran","Reddy, Mettu Srinivas","Soin, Arvinder Singh","Derosas, Carlos","Imventarza, Oscar","Isaac, John","Muiesan, Paolo","Mirza, Darius F","Bonney, Glenn Kunnath"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454041","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.jhep.2020.05.023","keywords":["covid-19","equipoise","ethics","liver transplantation"],"topics":["Prevention"],"weight":1,"_version_":1667881798554615808,"score":183.43394},{"pmid":32476233,"title":"Strategies for Liver Transplantation during the SARS CoV-2 Outbreak Preliminary Experience from a Single Center in France.","text":["Strategies for Liver Transplantation during the SARS CoV-2 Outbreak Preliminary Experience from a Single Center in France.","Liver transplantation during the ongoing SARS-CoV-2 pandemic is challenging given the urgent need to reallocate resources to other areas of patient care. Available guidelines recommend to reorganize transplant care but data on clinical experience in the context of SARS-CoV-2 pandemic are scarce. Thus, we report strategies and preliminary results in liver transplantation during the peak of the SARS-CoV-2 pandemic from a single-center in France. Our strategy to reorganize the transplant program included four main steps: optimization of available resources especially intensive care unit capacity, multidisciplinary risk stratification of liver transplantation candidates on the waiting list, implementation of a systematic SARS-CoV-2 screening strategy prior to transplantation and definition of optimal recipient-donor matching. After implementation of these four steps, we performed 10 successful liver transplantations during the peak of the pandemic with a short median intensive care unit stay (2,5 days), benchmark post-transplant morbidity and no occurrence of SARS-CoV-2 infection during follow-up. From this preliminary experience we conclude that efforts in resource planning, optimal recipient selection and organ allocation strategy are key to maintain a safe liver transplant activity. Transplant centers should be ready to readapt their practices as the pandemic evolves.","Am J Transplant","Muller, Xavier","Tilmans, Gilles","Chenevas-Paule, Quentin","Lebosse, Fanny","Antonini, Teresa","Poinsot, Domitille","Rode, Agnes","Guichon, Celine M","Schmitt, Zoe","Ducerf, Christian","Mohkam, Kayvan","Lesurtel, Mickael","Mabrut, Jean-Yves","32476233"],"abstract":["Liver transplantation during the ongoing SARS-CoV-2 pandemic is challenging given the urgent need to reallocate resources to other areas of patient care. Available guidelines recommend to reorganize transplant care but data on clinical experience in the context of SARS-CoV-2 pandemic are scarce. Thus, we report strategies and preliminary results in liver transplantation during the peak of the SARS-CoV-2 pandemic from a single-center in France. Our strategy to reorganize the transplant program included four main steps: optimization of available resources especially intensive care unit capacity, multidisciplinary risk stratification of liver transplantation candidates on the waiting list, implementation of a systematic SARS-CoV-2 screening strategy prior to transplantation and definition of optimal recipient-donor matching. After implementation of these four steps, we performed 10 successful liver transplantations during the peak of the pandemic with a short median intensive care unit stay (2,5 days), benchmark post-transplant morbidity and no occurrence of SARS-CoV-2 infection during follow-up. From this preliminary experience we conclude that efforts in resource planning, optimal recipient selection and organ allocation strategy are key to maintain a safe liver transplant activity. Transplant centers should be ready to readapt their practices as the pandemic evolves."],"journal":"Am J Transplant","authors":["Muller, Xavier","Tilmans, Gilles","Chenevas-Paule, Quentin","Lebosse, Fanny","Antonini, Teresa","Poinsot, Domitille","Rode, Agnes","Guichon, Celine M","Schmitt, Zoe","Ducerf, Christian","Mohkam, Kayvan","Lesurtel, Mickael","Mabrut, Jean-Yves"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32476233","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/ajt.16082","locations":["France","optimal","optimal","France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Prevention"],"weight":1,"_version_":1668437834987470848,"score":165.66983}]}